Literature DB >> 18210019

[28-year old patient with successfully treated dilatative cardiomyopathy].

E Burri1, M Decker, U Eriksson, P Buser, L Hunziker.   

Abstract

A 28-year was admitted with heart failure. His medical history included treatment for hypogonadotropic hypogonadism. Echocardiography showed dilatation of all chambers. Elevated serum ferritin levels and liver biopsy indicated hereditary hemochromatosis. Cardiac iron overload was seen on magnetic resonance imaging. Genetic testing revealed homozygosis for G320 V mutation, confirming the diagnosis of juvenile hemochromatosis. Phlebotomy on a biweekly regimen was started and after twelve months of therapy the patient had normal ferritin values as well as normal ejection fraction on echocardiography.

Entities:  

Mesh:

Year:  2008        PMID: 18210019     DOI: 10.1007/s00108-007-2007-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  8 in total

1.  A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.

Authors:  M A Tanner; R Galanello; C Dessi; G C Smith; M A Westwood; A Agus; M Roughton; R Assomull; S V Nair; J M Walker; D J Pennell
Journal:  Circulation       Date:  2007-03-19       Impact factor: 29.690

2.  Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.

Authors:  Caterina Borgna-Pignatti; Maria Domenica Cappellini; Piero De Stefano; Giovanni Carlo Del Vecchio; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Maria Antonietta Romeo; Huaqing Zhao; Avital Cnaan
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

Review 3.  Management of hemochromatosis. Hemochromatosis Management Working Group.

Authors:  J C Barton; S M McDonnell; P C Adams; P Brissot; L W Powell; C Q Edwards; J D Cook; K V Kowdley
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

4.  Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin.

Authors:  Lan Lin; Y Paul Goldberg; Tomas Ganz
Journal:  Blood       Date:  2005-07-05       Impact factor: 22.113

5.  Four-year evaluation of myocardial and liver iron assessed prospectively with serial MRI scans in young patients with beta-thalassaemia major: comparison between different chelation regimens.

Authors:  Athanasios Christoforidis; Afroditi Haritandi; Ioanna Tsatra; Ioannis Tsitourides; Stavroula Karyda; Miranda Athanassiou-Metaxa
Journal:  Eur J Haematol       Date:  2006-09-28       Impact factor: 2.997

6.  Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH).

Authors:  Giovanna Fabio; Francesca Minonzio; Paola Delbini; Annamaria Bianchi; Maria Domenica Cappellini
Journal:  Blood       Date:  2006-09-07       Impact factor: 22.113

7.  A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major.

Authors:  Sophie I Mavrogeni; Vyron Markussis; Loukas Kaklamanis; Dimitrios Tsiapras; Ioannis Paraskevaidis; George Karavolias; Markisia Karagiorga; Marouso Douskou; Dennis V Cokkinos; Dimitrios T Kremastinos
Journal:  Eur J Haematol       Date:  2005-09       Impact factor: 2.997

8.  Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases.

Authors:  Peter Nielsen; Roland Fischer; Peter Buggisch; Gritta Janka-Schaub
Journal:  Br J Haematol       Date:  2003-12       Impact factor: 6.998

  8 in total
  2 in total

Review 1.  A 56-year-old man with co-prevalence of Leriche syndrome and dilated cardiomyopathy: case report and review.

Authors:  Karsten Keller; Johannes Beule; Jörn Oliver Balzer; Meike Coldewey; Thomas Munzel; Wolfgang Dippold; Philipp Wild
Journal:  Wien Klin Wochenschr       Date:  2013-12-17       Impact factor: 1.704

Review 2.  Genotypic and phenotypic spectra of hemojuvelin mutations in primary hemochromatosis patients: a systematic review.

Authors:  Xiaomu Kong; Lingding Xie; Haiqing Zhu; Lulu Song; Xiaoyan Xing; Wenying Yang; Xiaoping Chen
Journal:  Orphanet J Rare Dis       Date:  2019-07-08       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.